ArticleiScience2025
An enhancing diagnostic pulmonary diseases diagnostic method for differentiating talaromycosis from tuberculosis.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comorbidity of chronic obstructive pulmonary disease and pulmonary tuberculosis: a bibliometric analysis (2011-2025) with narrative review.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Talaromycosis (TSM) affects immunocompromised individuals, particularly those with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), causing varied pulmonary abnormalities on chest computed tomography (CT). These features overlap with pulmonary tuberculosis, making accurate differentiation essential for appropriate treatment. This study utilized real patient data from the First Affiliated Hospital of Wenzhou Medical University. A machine learning model, termed bIPCACO-FKNN, was developed, integrating an ant colony optimization (ACO) algorithm with a fuzzy k-nearest neighbors (FKNNs) classifier. This model introduces an incremental proportional-integral-derivative control strategy to enhance the search efficiency of ACO. Comparative analysis with several algorithms in the CEC 2017 benchmark functions confirms the superior performance of the IPCACO. Applying the bIPCACO-FKNN model for the prediction of pulmonary TSM achieved a prediction accuracy of 98.196% and a specificity of 99.500%, thus demonstrating its significant efficacy in accurately distinguishing between pulmonary TSM and tuberculosis. This provides an efficient and reliable machine learning tool for the differentiation between pulmonary TSM and tuberculosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.